330 related articles for article (PubMed ID: 3917924)
41. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
42. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
43. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
44. Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity.
Boraschi D; Ghezzi P; Pasqualetto E; Salmona M; Nencioni L; Soldateschi D; Villa L; Tagliabue A
Immunology; 1983 Nov; 50(3):359-68. PubMed ID: 6354920
[TBL] [Abstract][Full Text] [Related]
45. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
[TBL] [Abstract][Full Text] [Related]
46. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
47. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
48. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
Bogdan C; Stenger S; Röllinghoff M; Solbach W
Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
[TBL] [Abstract][Full Text] [Related]
49. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
50. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
Brown TJ; Lioubin MN; Marquardt H
J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
[TBL] [Abstract][Full Text] [Related]
51. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
52. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
53. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
54. Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones.
Andrew PW; Rees AD; Scoging A; Dobson N; Matthews R; Whittall JT; Coates AR; Lowrie DB
Eur J Immunol; 1984 Oct; 14(10):962-4. PubMed ID: 6436035
[TBL] [Abstract][Full Text] [Related]
55. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
56. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
57. Entamoeba histolytica extract and interferon-gamma activation of macrophage-mediated amoebicidal function.
Ghadirian E; Denis M
Immunobiology; 1992 Jun; 185(1):1-10. PubMed ID: 1398736
[TBL] [Abstract][Full Text] [Related]
58. Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cells.
Jones CM; Prince CA; Langford MP; Hester JP
J Immunol; 1986 Jul; 137(2):571-7. PubMed ID: 3088103
[TBL] [Abstract][Full Text] [Related]
59. Characterization of lymphokine-mediated activation of macrophages for antigen presentation: studies with long-term cultured bone marrow-derived macrophages and cloned T cells.
Fischer HG; Reske-Kunz AB; Spaeth E; Kirchner H; Rüde E
Immunobiology; 1984 Dec; 168(3-5):232-45. PubMed ID: 6442269
[TBL] [Abstract][Full Text] [Related]
60. Bone marrow macrophages induced to antigen presentation by lymphokines interact selectively with distinct T cells.
Fischer HG; Reske-Kunz AB; Spaeth E; Rüde E
Eur J Immunol; 1985 Sep; 15(9):957-60. PubMed ID: 3876225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
